SCHEMBL360416

SCHEMBL360416

N#Cc1cc2nc(-n3ccc(N)n3)sc2cc1F

nearest known ligand 0.41

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CA2 P00918 8/20 0.41
CA9 Q16790 8/20 0.41
CA12 O43570 7/20 0.41
CA1 P00915 4/20 0.41
HRH3 Q9Y5N1 2/20 0.37
KCNH2 Q12809 1/20 0.32
KHK P50053 1/20 0.31
EGLN2 Q96KS0 1/20 0.31
NPC1 O15118 2/20 0.31
RAB9A P51151 2/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
USP30 Q70CQ3 2/20 0.30
CYP11B1 P15538 1/20 0.30
CYP11B2 P19099 1/20 0.30
ALDH1A1 P00352 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL360234 0.74 AXL (0.49) KCNH2KHKNPC1RAB9ASMN1; SMN2
SCHEMBL360263 0.72 RAB9A (0.55) NPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL359189 0.71 HTT (0.54) CA2CA9CA12CA1NPC1
SCHEMBL361030 0.68 KHK (0.40) KHKEGLN2CYP11B1CYP11B2
SCHEMBL20570918 0.68 AXL (0.49) KCNH2KHKNPC1RAB9ASMN1; SMN2
SCHEMBL25604312 0.68 SMN1; SMN2 (0.53) NPC1RAB9ASMN1; SMN2CYP11B1CYP11B2
SCHEMBL360852 0.68 MAPT (0.58) CA2CA9CA12CA1NPC1
SCHEMBL359742 0.67 GAA (0.41) CA2CA9CA12CA1NPC1
SCHEMBL25607091 0.66 CYP11B2 (0.39) KHKCYP11B2ALDH1A1
SCHEMBL26189895 0.63 MAOB (0.40) CYP11B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012007510-A1 COMPOUNDS FOR BINDING AND IMAGING AMYLOID PLAQUES AND THEIR USE BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2012-01-19 WO claimed
WO-2012007510-A1 COMPOUNDS FOR BINDING AND IMAGING AMYLOID PLAQUES AND THEIR USE BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2012-01-19 WO disclosed